Ligand Pharmaceuticals | Cassa E Equivalenti

Prezzo Delle Azioni
185.60
Cambio Giornaliero
-1.33 -0.71%
Mensile
-10.26%
Annuale
64.58%
Q1 Previsione
184.59




Cassa E Equivalenti Cambiamento Data
Agenus USD 3.46M 6.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Anika Therapeutics USD 57.99M 4.82M 2025-09
Arrowhead Research USD 201.64M 112.94M 2025-12
Baxter International USD 1.73B 40M 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Eli Lilly USD 9.79B 6.42B 2025-09
Enanta Pharmaceuticals USD 32.3M 12.51M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Glaxosmithkline GBP 3.3B 303M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Insmed USD 334.76M 949.56M 2025-09
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Ligand Pharmaceuticals USD 664.52M 596.85M 2025-09
MacroGenics USD 80.13M 50.56M 2025-09
Merck USD 18.17B 10.16B 2025-09
Pacira USD 147.59M 152.89M 2025-09
Pfizer USD 1.34B 295M 2025-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Veracyte USD 315.57M 96.07M 2025-09


Ligand Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.